01.09.2026
Schellenberg Wittmer acted as Swiss counsel for Marubeni Corporation on the acquisition of Swiss TOLUS Group AG.
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
23.07.2026
Schellenberg Wittmer acts as Swiss counsel to Enilive on its acquisition of all shares in OIL! Tankstellen GmbH, a company operating in the mobility retail business in Germany, …
07.07.2026
29.05.2026
Schellenberg Wittmer advised OC Oerlikon as lead counsel on its placement of CHF 200 million senior unsecured bonds.